Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Frédéric Courtier"'
Autor:
Frédéric Courtier, Nadine Carbuccia, Séverine Garnier, Arnaud Guille, José Adélaïde, Nathalie Cervera, Véronique Gelsi-Boyer, Marie-Joelle Mozziconacci, Jérôme Rey, Norbert Vey, Max Chaffanet, Daniel Birnbaum, Anne Murati
Publikováno v:
Haematologica, Vol 102, Iss 1 (2017)
Externí odkaz:
https://doaj.org/article/71456fbe61dd4648a3f7605400fc1cdb
Autor:
Mathias Neron, Arnaud Guille, Lucie Allegre, Pierre-Emmanuel Colombo, Cristina Leaha, José Adelaide, Nadine Carbuccia, Frédéric Courtier, Florence Boissiere, Evelyne Crapez, Michel Fabbro, Sébastien Gouy, Emilie Mamessier, Éric Lambaudie, Daniel Birnbaum, François Bertucci, Max Chaffanet
Publikováno v:
Journal of Personalized Medicine
Journal of Personalized Medicine, 2022, 12 (5), pp.655. ⟨10.3390/jpm12050655⟩
Journal of Personalized Medicine; Volume 12; Issue 5; Pages: 655
Journal of Personalized Medicine, 2022, 12 (5), pp.655. ⟨10.3390/jpm12050655⟩
Journal of Personalized Medicine; Volume 12; Issue 5; Pages: 655
International audience; Hormone therapy (HT) is an effective treatment for metastatic endometrial carcinoma (mEC), with limited toxicity and low cost. We focused on molecular analysis of mECs treated by HT and, for the first time to date, we compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aabfe58bbcafbd3bcf44e1ae0e378d3e
https://hal.science/hal-03765663/document
https://hal.science/hal-03765663/document
Autor:
Cedric Pastoret, Yves Delneste, Sylvain Thepot, Marie-Christine Rousselet, Damien Luque Paz, Jean-Marie Chrétien, Maxime Renard, Jean-Christophe Ianotto, Odile Blanchet, Mathilde Hunault-Berger, Jean-Claude Chomel, Anne Murati, Norbert Ifrah, Maria-Pilar Gallego-Hernanz, Isabelle Quintin-Roué, Laurane Cottin, Aurélie Chauveau, Jérémie Riou, Frédéric Courtier, Françoise Boyer, Corentin Orvain, Valérie Ugo, Emilie Cayssials, Rébecca Jouanneau-Courville, Eric Lippert
Publikováno v:
Blood Adv
Blood Advances
Blood Advances, The American Society of Hematology, 2020, 4 (19), pp.4887-4897. ⟨10.1182/bloodadvances.2020002271⟩
Blood Advances, 2020, 4 (19), pp.4887-4897. ⟨10.1182/bloodadvances.2020002271⟩
Blood Advances
Blood Advances, The American Society of Hematology, 2020, 4 (19), pp.4887-4897. ⟨10.1182/bloodadvances.2020002271⟩
Blood Advances, 2020, 4 (19), pp.4887-4897. ⟨10.1182/bloodadvances.2020002271⟩
Among myeloproliferative neoplasms, polycythemia vera (PV) and essential thrombocythemia (ET) are the 2 entities associated with the most chronic disease course. Leukemic evolution occurs rarely but has a grim prognosis. The interval between diagnosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ab52f4852b2f32a329574469f02ecfb
https://europepmc.org/articles/PMC7556129/
https://europepmc.org/articles/PMC7556129/
Autor:
Valérie Ugo, Nadine Carbuccia, Anne Murati, José Adélaïde, François Delhommeau, Frédéric Courtier, Max Chaffanet, Norbert Vey, Arnaud Guille, Bohrane Slama, Damien Luque Paz, Jerome Rey, Séverine Garnier, Pierre Hirsch, Daniel Birnbaum
Publikováno v:
Genes, Chromosomes & Cancer
Genes, Chromosomes & Cancer, 2019, 59 (1), pp.30-39. ⟨10.1002/gcc.22789⟩
Genes, Chromosomes & Cancer, 2019, 59 (1), pp.30-39. ⟨10.1002/gcc.22789⟩
INTRODUCTION In BCR-ABL1-negative myeloproliferative neoplasms, myelofibrosis (MF) is either primary (PMF) or secondary (SMF) to polycythemia vera or essential thrombocythemia. MF is characterized by an increased risk of transformation to acute myelo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e64870cc4389065b6acb518cf6a87bf9
https://hal.science/hal-03634203
https://hal.science/hal-03634203
Autor:
Séverine Garnier, Jerome Rey, M J Mozziconacci, Anne Murati, Arnaud Guille, Frédéric Courtier, Anne Wanquet, Nadine Carbuccia, Véronique Gelsi-Boyer, Norbert Vey, José Adélaïde, Daniel Birnbaum
Publikováno v:
Leukemialymphoma. 60(5)
Myeloproliferative neoplasms (MPNs) are clonal disorders characterized by myeloproliferation and predisposition to bone marrow fibrosis. Philadelphia-negative classical MPNs comprise essential thro...
Autor:
Jerome Rey, Geoffroy Venton, Bilal Mohty, Aude Charbonnier, Anne Murati, Daniel Birnbaum, Marie-Joelle Mozziconacci, Norbert Vey, Frédéric Courtier, Colombe Saillard, Evelyne D'Incan
Publikováno v:
American Journal of Hematology
American Journal of Hematology, Wiley, 2018, 93 (3), pp.330-338. ⟨10.1002/ajh.24973⟩
American Journal of Hematology, 2018, 93 (3), pp.330-338. ⟨10.1002/ajh.24973⟩
American Journal of Hematology, Wiley, 2018, 93 (3), pp.330-338. ⟨10.1002/ajh.24973⟩
American Journal of Hematology, 2018, 93 (3), pp.330-338. ⟨10.1002/ajh.24973⟩
International audience; Acute myeloid leukemias secondary (sAML) to myeloproliferative neoplasms (MPN) have variable clinical courses and outcomes, but remain almost always fatal. Large cohorts of sAML to MPN are difficult to obtain and there is very
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b283396e6ccaf5fec241dea438bc367
https://hal.archives-ouvertes.fr/hal-01788547
https://hal.archives-ouvertes.fr/hal-01788547
Autor:
Véronique Gelsi-Boyer, Daniel Birnbaum, Norbert Vey, Arnaud Guille, Anne Murati, Max Chaffanet, Séverine Garnier, Nathalie Cervera, Marie-Joelle Mozziconacci, Jérôme Rey, Frédéric Courtier, José Adélaïde, Nadine Carbuccia
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2016, 102 (1), pp.e11-e14. ⟨10.3324/haematol.2016.152363⟩
Haematologica, 2016, 102 (1), pp.e11-e14. ⟨10.3324/haematol.2016.152363⟩
Haematologica, Ferrata Storti Foundation, 2016, 102 (1), pp.e11-e14. ⟨10.3324/haematol.2016.152363⟩
Haematologica, 2016, 102 (1), pp.e11-e14. ⟨10.3324/haematol.2016.152363⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8709b57e55e7d2f1d788a5b27914d6fc
https://hal.archives-ouvertes.fr/hal-01789589
https://hal.archives-ouvertes.fr/hal-01789589
Autor:
Antoine Wagner, Michèle Rouleau, Lyne Villeneuve, Trang Le, Cheryl Peltier, Éric P. Allain, Caroline Beaudoin, Sophie Tremblay, Fréderic Courtier, Flora Nguyen Van Long, Isabelle Laverdière, Éric Lévesque, Versha Banerji, Katrina Vanura, Chantal Guillemette
Publikováno v:
Cells, Vol 12, Iss 9, p 1295 (2023)
In chronic lymphocytic leukemia (CLL), an elevated glycosyltransferase UGT2B17 expression (UGT2B17HI) identifies a subgroup of patients with shorter survival and poor drug response. We uncovered a mechanism, possibly independent of its enzymatic func
Externí odkaz:
https://doaj.org/article/85e34fb2de6d4a829f62b96745bfae7d